Brief: Evaxion Biotech Q1 Basic EPS USD 0.03
28/05/2024 13:21
May 28 (Reuters) - Evaxion Biotech Q1 operating income USD -4.396 million. * Q1 net income USD 1.194 million * Q1 pretax profit USD 976 thousand
Recent news on Evaxion A/S
See all newsEvaxion A/S reports results for the quarter ended June 30 - Earnings Summary
Denmark's Evaxion Q2 net loss narrows on lower expenses
Brief: Evaxion Q2 Basic EPS USD -0.01
Evaxion A/S expected to post a loss of 31 cents a share - Earnings Preview
Brief: Evaxion A/S - Expands Pipeline Of Cancer Vaccine Programs With Evx-05 Against Brain Cancer Glioblastoma